Varian Medical Systems stock got clobbered July 14, dropping nearly $8 per share to about $67, after the company reported that orders for oncology equipment from North American customers were flat in the fiscal third quarter. The announcement was made
Varian Medical Systems stock got clobbered July 14, dropping nearly $8 per share to about $67, after the company reported that orders for oncology equipment from North American customers were flat in the fiscal third quarter. The announcement was made ahead of the scheduled July 29 earnings release in response to high-volume, volatile trading. The knee-jerk reaction to the announcement reflects the importance of the U.S. market, as it was swaddled in otherwise good news-an expected 30% jump in overall earnings on a 14% rise in sales per share for the third quarter compared with the previous year's period.
Mammography Study Compares False Positives Between AI and Radiologists in DBT Screening
May 8th 2025For DBT breast cancer screening, 47 percent of radiologist-only flagged false positives involved mass presentations whereas 40 percent of AI-only flagged false positive cases involved benign calcifications, according to research presented at the recent American Roentgen Ray Society (ARRS) conference.